Adtalem Global Education (NYSE:CVSA) SVP Douglas Beck Sells 4,526 Shares of Stock

Adtalem Global Education Inc. (NYSE:CVSA) SVP Douglas Beck sold 4,526 shares of the company’s stock in a transaction that occurred on Friday, August 7th. The stock was sold at an average price of $135.81, for a total value of $614,676.06. Following the sale, the senior vice president owned 28,544 shares of the company’s stock, valued at $3,876,560.64. This trade represents a 13.69% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Price Performance

Shares of NYSE CVSA opened at $125.98 on Wednesday. The business’s fifty day moving average is $124.90. Adtalem Global Education Inc. has a 1-year low of $86.97 and a 1-year high of $156.26. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.45. The firm has a market capitalization of $4.29 billion, a P/E ratio of 17.89, a PEG ratio of 0.95 and a beta of 0.62.

Adtalem Global Education (NYSE:CVSA) last announced its quarterly earnings data on Thursday, August 6th. The company reported $2.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.90 by $0.19. The company had revenue of $501.38 million for the quarter. Adtalem Global Education had a net margin of 12.87% and a return on equity of 20.88%. Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS. Analysts anticipate that Adtalem Global Education Inc. will post 8.99 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on CVSA shares. Wall Street Zen upgraded shares of Adtalem Global Education from a “hold” rating to a “buy” rating in a research note on Saturday. Weiss Ratings restated a “hold (c+)” rating on shares of Adtalem Global Education in a research report on Friday, May 22nd. Truist Financial lifted their price objective on Adtalem Global Education from $130.00 to $140.00 and gave the company a “buy” rating in a report on Monday, May 11th. Finally, Barrington Research reiterated an “outperform” rating and set a $170.00 target price on shares of Adtalem Global Education in a research report on Monday, June 8th. Two equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $155.00.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.